The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
New perspectives in the natural history of multiple sclerosis
Abstract
Multiple sclerosis (MS) has entered an era of immunomodulatory drug treatment, the impact of which on long-term disease progression remains controversial. The increasing use of these therapies has intensified our need to understand the true natural history of MS. The MS community is poised to establish whether the immunomodulatory drugs exhibit long-term benefits, with a suitable untreated natural history cohort likely the most practical and ethical comparator group. Thus, a thorough understanding of the natural history of MS is fundamental. In this review, we highlight recent advances in MS natural history over the last 5 years, with a focus on long-term population-based cohorts and factors associated with disease progression. Survival in MS has increased and longer times to irreversible disability have been reported in contemporary studies, indicating a slower accumulation of disability. Wide variation in the MS disease trajectory is evident within and between natural history studies, reflecting both methodologic considerations related to data collection and heterogeneity of disease activity. Recent publications have indicated that a younger age at disease onset is no longer indicative of a favorable outcome and further evidence supports the dissociation between relapses and long-term disability, although windows of opportunity may exist for some patients. We are now perhaps faced with our last chance to examine the true natural history of MS, so whether the reader is a practicing physician, health care provider, or researcher, or engaged in the pharmaceutical industry or in clinical trial design, recent advances in our understanding of the natural history of MS are of key significance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Defining the clinical course of multiple sclerosis: Results of an international survey
Lublin, F. D., Reingold, S. C., & National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis* (1996) · Neurology · doi:10.1212/wnl.46.4.907 · Cited by 3,686
WEINSHENKER, B. G., BASS, B., RICE, G. P. A., NOSEWORTHY, J., CARRIERE, W., BASKERVILLE, J., & EBERS, G. C. (1989) · Brain · doi:10.1093/brain/112.1.133 · Cited by 1,452
Relapses and Progression of Disability in Multiple Sclerosis
Confavreux, C., Vukusic, S., Moreau, T., & Adeleine, P. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011163432001 · Cited by 1,309
The natural history of multiple sclerosis:a geographically based study
Cottrell, D. A., Kremenchutzky, M., Rice, G. P. A., Koopman, W. J., Hader, W., Baskerville, J., & Ebers, G. C. (1999) · Brain · doi:10.1093/brain/122.4.625 · Cited by 1,163
Confavreux, C. (2003) · Brain · doi:10.1093/brain/awg081 · Cited by 996
Natural history of multiple sclerosis: a unifying concept
Confavreux, C., & Vukusic, S. (2006) · Brain · doi:10.1093/brain/awl007 · Cited by 905
Fisniku, L. K., Brex, P. A., Altmann, D. R., Miszkiel, K. A., Benton, C. E., Lanyon, R., Thompson, A. J., & Miller, D. H. (2008) · Brain · doi:10.1093/brain/awm329 · Cited by 897
(2006) · Elsevier eBooks · doi:10.1016/b978-0-443-07271-0.x5001-0 · Cited by 769
Temporal trends in the incidence of multiple sclerosis: A systematic review
Alonso, A., & Hernán, M. A. (2008) · Neurology · doi:10.1212/01.wnl.0000316802.35974.34 · Cited by 694
WEINSHENKER, B. G., BASS, B., RICE, G. P. A., NOSEWORTHY, J., CARRIERE, W., BASKERVILLE, J., & EBERS, G. C. (1989) · Brain · doi:10.1093/brain/112.6.1419 · Cited by 602
Natural History of Multiple Sclerosis with Childhood Onset
Renoux, C., Vukusic, S., Mikaeloff, Y., Edan, G., Clanet, M., Dubois, B., Debouverie, M., Brochet, B., Lebrun-Frenay, C., Pelletier, J., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa067597 · Cited by 598
Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up
Runmarker, B., & Andersen, O. (1993) · Brain · doi:10.1093/brain/116.1.117 · Cited by 568
Age at disability milestones in multiple sclerosis
Confavreux, C., & Vukusic, S. (2006) · Brain · doi:10.1093/brain/awh714 · Cited by 525
The natural history of multiple sclerosis with childhood onset
Renoux, C., Vukusic, S., & Confavreux, C. (2008) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2008.04.009 · Cited by 450
Kremenchutzky, M., Rice, G. P. A., Baskerville, J., Wingerchuk, D. M., & Ebers, G. C. (2006) · Brain · doi:10.1093/brain/awh721 · Cited by 447
Wolinsky, J. S., Narayana, P. A., O'Connor, P., Coyle, P. K., Ford, C., Johnson, K., Miller, A., Pardo, L., Kadosh, S., Ladkani, D., et al. (2007) · Annals of Neurology · doi:10.1002/ana.21079 · Cited by 429
Effect of relapses on development of residual deficit in multiple sclerosis
Lublin, F. D., Baier, M., & Cutter, G. (2003) · Neurology · doi:10.1212/01.wnl.0000096175.39831.21 · Cited by 421
WEINSHENKER, B. G., RICE, G. P. A., NOSEWORTHY, J. H., CARRIERE, W., BASKERVILLE, J., & EBERS, G. C. (1991) · Brain · doi:10.1093/brain/114.2.1045 · Cited by 401
Disability progression in multiple sclerosis is slower than previously reported
Tremlett, H., Paty, D., & Devonshire, V. (2006) · Neurology · doi:10.1212/01.wnl.0000194259.90286.fe · Cited by 343
Self-citationTrends in survival and cause of death in Danish patients with multiple sclerosis
Bronnum-Hansen, H. (2004) · Brain · doi:10.1093/brain/awh104 · Cited by 282
General Right Censoring and Its Impact on the Analysis of Survival Data
Lagakos, S. W. (1979) · Biometrics · doi:10.2307/2529941 · Cited by 279
Relapses in multiple sclerosis are age- and time-dependent
Tremlett, H., Zhao, Y., Joseph, J., Devonshire, V, & Neurologists*, T. U. C. (2008) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2008.145805 · Cited by 277
Self-citationThe natural history of secondary progressive multiple sclerosis
Koch, M., Kingwell, E., Rieckmann, P., Tremlett, H., & Neurologists, U. M. C. (2010) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2010.208173 · Cited by 241
Self-citationImpact of multiple sclerosis relapses on progression diminishes with time
Tremlett, H., Yousefi, M., Devonshire, V., Rieckmann, P., & Zhao, Y. (2009) · Neurology · doi:10.1212/wnl.0b013e3181c1e44f · Cited by 221
Self-citationEriksson, M., Andersen, O., & Runmarker, B. (2003) · Multiple Sclerosis Journal · doi:10.1191/1352458503ms914oa · Cited by 221
Natural history of secondary-progressive multiple sclerosis
Tremlett, H., Zhao, Y., & Devonshire, V. (2008) · Multiple Sclerosis Journal · doi:10.1177/1352458507084264 · Cited by 217
Self-citationClinical implications of benign multiple sclerosis: A 20‐year population‐based follow‐up study
Pittock, S. J., McClelland, R. L., Mayr, W. T., Jorgensen, N. W., Weinshenker, B. G., Noseworthy, J., & Rodriguez, M. (2004) · Annals of Neurology · doi:10.1002/ana.20197 · Cited by 211
Myhr, K., Riise, T., Vedeler, C. A., Nortvedt, M. W., Grønning, M., Midgard, R., & Nyland, H. (2001) · Multiple Sclerosis Journal · doi:10.1177/135245850100700110 · Cited by 184
Joseph, F., Hirst, C. L., Pickersgill, T. P., Ben‐Shlomo, Y., Robertson, N. P., & Scolding, N. J. (2008) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2008.150896 · Cited by 178
Survival and predictors of disability in Turkish MS patients
Kantarci, O., Siva, A., Eraksoy, M., Karabudak, R., Sütlaş, N., Ağaoğlu, J., Turan, F., Özmenoğlu, M., Toğrul, E., Demirkiran, M., et al. (1998) · Neurology · doi:10.1212/wnl.51.3.765 · Cited by 168
The natural history of multiple sclerosis
Confavreux, C., & Compston, A. (2006) · McAlpine's Multiple Sclerosis · doi:10.1016/b978-0-443-07271-0.50006-9 · Cited by 166
Natural history of multiple sclerosis in a population‐based cohort
Debouverie, M., Pittion‐Vouyovitch, S., Louis, S., Guillemin, F., & for the LORSEP Group (2008) · European Journal of Neurology · doi:10.1111/j.1468-1331.2008.02241.x · Cited by 163
Longitudinal follow-up of “benign” multiple sclerosis at 20 years
Sayao, A., Devonshire, V. A., & Tremlett, H. L. (2007) · Neurology · doi:10.1212/01.wnl.0000253185.03943.66 · Cited by 158
Self-citationContribution of relapses to disability in multiple sclerosis
Hirst, C. L., Ingram, G., Pearson, O. R., Pickersgill, T. P., Scolding, N. J., & Robertson, N. P. (2008) · Journal of Neurology · doi:10.1007/s00415-008-0743-8 · Cited by 156
Disability profile of MS did not change over 10 years in a population-based prevalence cohort
Pittock, S. J., Mayr, W. T., McClelland, R. L., Jorgensen, N. W., Weigand, S. D., Noseworthy, J. H., & Rodriguez, M. (2004) · Neurology · doi:10.1212/wnl.62.4.601 · Cited by 146
Torkildsen, N. G., Lie, S. A., Aarseth, J. H., Nyland, H., & Myhr, K.-M. (2008) · Multiple Sclerosis Journal · doi:10.1177/1352458508093890 · Cited by 138
Clinical characteristics of patients with late-onset multiple sclerosis
Kis, B., Rumberg, B., & Berlit, P. (2008) · Journal of Neurology · doi:10.1007/s00415-008-0778-x · Cited by 137
Is late-onset multiple sclerosis associated with a worse outcome?
Tremlett, H. L., & Devonshire, V. A. (2006) · Neurology · doi:10.1212/01.wnl.0000237475.01655.9d · Cited by 136
Self-citationDeLuca, G. C., Ramagopalan, S. V., Herrera, B. M., Dyment, D. A., Lincoln, M. R., Montpetit, A., Pugliatti, M., Barnardo, M., RISCH, N. J., Sadovnick, A. D., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707731105 · Cited by 135
Course and prognosis of chronic progressive multiple sclerosis: Results of an epidemiological study
Minderhoud, J. M., van der Hoeven, J. H., & Prange, A. J. A. (1988) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1988.tb03611.x · Cited by 126
Vukusic, S., & Confavreux, C. (2003) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(02)00426-4 · Cited by 126
Amato, M. P., Portaccio, E., Stromillo, M. L., Goretti, B., Zipoli, V., Siracusa, G., Battaglini, M., Giorgio, A., Bartolozzi, M. L., Guidi, L., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000324621.58447.00 · Cited by 120
Predicting progression in primary progressive multiple sclerosis: A 10‐year multicenter study
Khaleeli, Z., Ciccarelli, O., Manfredonia, F., Barkhof, F., Brochet, B., Cercignani, M., Dousset, V., Filippi, M., Montalbán, X., Polman, C. H., et al. (2008) · Annals of Neurology · doi:10.1002/ana.21375 · Cited by 111
Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis
Portaccio, E., Stromillo, M. L., Goretti, B., Zipoli, V., Siracusa, G., Battaglini, M., Giorgio, A., Bartolozzi, M. L., Guidi, L., Sorbi, S., et al. (2009) · Neurology · doi:10.1212/wnl.0b013e3181b351fd · Cited by 108
Progression in multiple sclerosis: Further evidence of an age dependent process
Koch, M. W., Mostert, J. P., Heersema, D. J., & Keyser, J. D. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2007.01.067 · Cited by 104
Mortality in multiple sclerosis: a review
Ragonese, P., Aridon, P., Salemi, G., D’Amelio, M., & Savettieri, G. (2008) · European Journal of Neurology · doi:10.1111/j.1468-1331.2007.02019.x · Cited by 103
The natural history of primary progressive MS in British Columbia, Canada
Tremlett, H. L., Paty, D. W., & Devonshire, V. A. (2005) · Neurology · doi:10.1212/01.wnl.0000188880.17038.1d · Cited by 102
Self-citationCognitive impairment and structural brain damage in benign multiple sclerosis
Rovaris, M., Riccitelli, G. C., Judica, E., Possa, F., Caputo, D., Ghezzi, A., Bertolotto, A., Capra, R., Falautano, M., Mattioli, F., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000319694.14251.95 · Cited by 99
Familial effects on the clinical course of multiple sclerosis
Hensiek, A. E., Seaman, S. R., Barcellos, L. F., Oturai, A. B., Eraksoi, M., Cocco, E. E., Vécsei, L., Stewart, G. J., Dubois, B., Bellman-Strobl, J., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000252822.53506.46 · Cited by 90
Neurologists, A. T. U., Tremlett, H. L., Zhao, Y., & Devonshire, V. A. (2009) · Journal of Neurology · doi:10.1007/s00415-009-0039-7 · Cited by 84
Self-citationImitola, J., Chitnis, T., & Khoury, S. J. (2006) · Archives of Neurology · doi:10.1001/archneur.63.1.25 · Cited by 82
Age at onset determines the occurrence of the progressive phase of multiple sclerosis
Stankoff, B., Mrejen, S., Tourbah, A., Fontaine, B., Lyon‐Caen, O., Lubetzki, C., & Rosenheim, M. (2007) · Neurology · doi:10.1212/01.wnl.0000256732.36565.4a · Cited by 60
Khaleeli, Z., Altmann, D., Cercignani, M., Ciccarelli, O., Miller, D. H., & Thompson, A. (2008) · Archives of Neurology · doi:10.1001/archneur.65.11.1454 · Cited by 58
A timing-of-birth effect on multiple sclerosis clinical phenotype
Sadovnick, A. D., Duquette, P., Herrera, B. M., Yee, I. M. L., & Ebers, G. C. (2007) · Neurology · doi:10.1212/01.wnl.0000265053.22905.64 · Cited by 57
Imrell, K., Greiner, E., Hillert, J. A., & Masterman, T. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.03.005 · Cited by 49
Predictive value of clinical characteristics for ‘benign’ multiple sclerosis
Ramsaransing, G. S. M., & Keyser, J. D. (2007) · European Journal of Neurology · doi:10.1111/j.1468-1331.2007.01810.x · Cited by 47
Factors associated with the risk of secondary progression in multiple sclerosis
Koch, M. W., Uyttenboogaart, M., van Harten, A. E., & Keyser, J. D. (2008) · Multiple Sclerosis Journal · doi:10.1177/1352458508089361 · Cited by 34
Multiple sclerosis with a progressive course from onset in Lorraine-Eastern France
Debouverie, M., Léonard-Louis, S., Pittion‐Vouyovitch, S., Roederer, T., & Vespignani, H. (2007) · Journal of Neurology · doi:10.1007/s00415-007-0554-3 · Cited by 22
Progression in familial and nonfamilial MS
Koch, M. W., Uyttenboogaart, M., Heerings, M. A. P., Heersema, D. J., Mostert, J. P., & Keyser, J. D. (2008) · Multiple Sclerosis Journal · doi:10.1177/1352458507084269 · Cited by 17
Long-term prognosis of multiple sclerosis in Australia
McLeod, J. G., Barnett, M. H., Macaskill, P., & Williams, D. B. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2007.02.004 · Cited by 10
Cited by
Multiple Sclerosis: Mechanisms and Immunotherapy
Baecher-Allan, C., Kaskow, B. J., & Weiner, H. L. (2018) · Neuron · doi:10.1016/j.neuron.2018.01.021 · Cited by 938
Natural History of Multiple Sclerosis Symptoms
Kister, I., Bacon, T. E., Chamot, E., Salter, A. R., Cutter, G. R., Kalina, J. T., & Herbert, J. (2013) · International Journal of MS Care · doi:10.7224/1537-2073.2012-053 · Cited by 450
Defining secondary progressive multiple sclerosis
Lorscheider, J., Buzzard, K., Jokubaitis, V., Spelman, T., Havrdova, E., Horakova, D., Trojano, M., Izquierdo, G., Girard, M., Duquette, P., et al. (2016) · Brain · doi:10.1093/brain/aww173 · Cited by 415
Serum Neurofilament Light Chain Levels in Patients With Presymptomatic Multiple Sclerosis
Bjornevik, K., Munger, K. L., Cortese, M., Barro, C., Healy, B. C., Niebuhr, D. W., Scher, A. I., Kuhle, J., & Ascherio, A. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2019.3238 · Cited by 269
Mortality in patients with multiple sclerosis
Scalfari, A., Knappertz, V., Cutter, G., Goodin, D. S., Ashton, R., & Ebers, G. C. (2013) · Neurology · doi:10.1212/wnl.0b013e31829a3388 · Cited by 261
Metadata
- Authors
- Tremlett, H., Zhao, Y., Rieckmann, P., & Hutchinson, M.
- Venue
- Neurology
- Published
- 2010-06-15
- Volume
- 74
- Issue
- 24
- Pages
- 2004-2015
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2004076487
- Cited by
- 261
- References
- 60
- FWCI
- 11.54
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.